About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
- WOMEN
- 2026 Readers' Choice Awards
Classifieds
Weather
Obituaries

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

229.97 -4.22 (-1.80%)

Streaming Delayed Price Updated: 2:31 PM EDT, Jul 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

19 20 21 22 23 24 25 26 Next >

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

68 Biggest Movers From Yesterday ↗

August 10, 2021

Gainers Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) shares climbed 50.8% to close at $18.50 on Monday after the company and DraftKings announced they entered into a...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Axsome Therapeutics, Inc. and Encourages Investors With Losses to Contact the Firm

August 09, 2021

From The Schall Law Firm

Via Business Wire

Axsome Therapeutics, inc (AXSM) Q2 2021 Earnings Call Transcript ↗

August 09, 2021

AXSM earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

AXSM INVESTOR ALERT: Rosen Law Firm Encourages Axsome Therapeutics, Inc. Investors with Losses to Inquire About Class Action Investigation – AXSM

August 09, 2021

From The Rosen Law Firm, P.A.

Via Business Wire

Mid-Afternoon Market Update: Aterian Falls After Q2 Results; Select Interior Concepts Shares Spike Higher ↗

August 09, 2021

Toward the end of trading Monday, the Dow traded down 0.17% to 35,150.02 while the NASDAQ rose 0.26% to 14,874.23. The S&P also rose, gaining 0.01% to 4,436.62. The U.S. has...

Via Benzinga

Topics Stocks

Dow, S&P 500 Pull Back Amid Record Job Openings ↗

August 09, 2021

The Dow Jones Industrial Average is down 70 points midday, pulling back from Friday's record highs as investors monitor choppy oil prices and the subsequent pressure on energy stocks.

Via Talk Markets

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 09, 2021

Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 33.66% to $4.3 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 87.6...

Via Benzinga

Mid-Day Market Update: Crude Oil Down 2.5%; Golden Nugget Online Gaming Shares Jump ↗

August 09, 2021

Midway through trading Monday, the Dow traded down 0.23% to 35,126.98 while the NASDAQ rose 0.20% to 14,866.01. The S&P also fell, dropping 0.08% to 4,432.96. The U.S. has the...

Via Benzinga

Topics Stocks

Why Axsome Therapeutics Stock Is Crashing Today ↗

August 09, 2021

An unexpected regulatory setback is weighing on the biotech's shares today.

Via The Motley Fool

Axsome Stock Drops To 52-Week Low On FDA Response Letter For Depression Candidate ↗

August 09, 2021

Wrapped up in its Q2 earnings release, Axsome Therapeutics Inc (NASDAQ: AXSM) said that on July 30, it received an FDA letter for a marketing application for AXS-...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

August 09, 2021

Before 10 a.m. ET Monday, 63 stocks made new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was PACCAR (NASDAQ:PCAR)....

Via Benzinga

Mid-Morning Market Update: Markets Mixed; DISH Network Profit Beats Estimates ↗

August 09, 2021

Following the market opening Monday, the Dow traded down 0.19% to 35,141.90 while the NASDAQ rose 0.10% to 14,850.40. The S&P also fell, dropping 0.07% to 4,433.63. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 09, 2021

Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 30.38% to $2.36 during Monday's pre-market session. The company's market cap stands at $61.9 million. The...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates ↗

August 02, 2021

The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 30, 2021

On Friday morning, 33 companies hit new 52-week lows. Areas of Significance: The largest company in terms of market cap to set a new 52-week low was Las Vegas Sands...

Via Benzinga

Is There Any Hope Left for Axsome Therapeutics? ↗

July 30, 2021

After a fantastic run-up, investors are now losing faith in this emerging biotech's stock.

Via The Motley Fool

Why Shares of Axsome Therapeutics Are Falling Today ↗

July 14, 2021

The FDA took back a beneficial designation but management isn't changing its plans.

Via The Motley Fool

Buy This Stock Before Everyone Else Does ↗

July 14, 2021

This biotech has significant upside left.

Via The Motley Fool

Ditch Dogecoin: These 3 Stocks Could Double Your Money ↗

June 23, 2021

The path to a twofold or greater return is straightforward for each of these stocks.

Via The Motley Fool

Axsome Therapeutics Targets Submission Of US Application For Fibromyalgia Candidate By 2022 ↗

June 15, 2021

After a pre-NDA meeting with FDA, Axsome Therapeutics Inc (NASDAQ: AXSM) has announced its plan to submit a marketing application seeking approval for AXS-14...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2021 ↗

June 10, 2021

Upgrades According to Argus Research, the prior rating for Zoom Video Communications Inc (NASDAQ:ZM) was changed from Hold to Buy. Zoom Video Communications earned $1.32...

Via Benzinga

2 Top Biotech Stocks to Buy for Summer 2021 ↗

June 05, 2021

Progress in these companies' drug development pipelines should give shareholders plenty to look forward to.

Via The Motley Fool

Axsome Therapeutics, Inc. (AXSM) Q1 2021 Earnings Call Transcript ↗

May 10, 2021

AXSM earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Parkinson’s Disease Therapeutic Market Revenue Is Expected To Cross $8 Billion By 2027

May 05, 2021

Via FinancialNewsMedia

2 Top Biotech Stocks to Buy Right Now ↗

April 30, 2021

The stocks of Novavax and Axsome Therapeutics are soaring. Here's why.

Via The Motley Fool

3 Biotech Stocks That Could Be Millionaire-Makers ↗

April 28, 2021

Their stocks have collapsed. But they could still be huge winners.

Via The Motley Fool

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

58 Biggest Movers From Yesterday ↗

April 27, 2021

Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial...

Via Benzinga

< Previous 1 2

...

19 20 21 22 23 24 25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

All News about Axsome Therapeutics, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us